A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits

British Journal of Pharmacology

Volumn 128, Issue 8, 1999, Pages 1667-1672

  Minatoguchi, Shinya ^a   Arai, Masazumi ^a   Uno, Yoshihiro ^a   Kariya, Tatsuya ^a   Nishida, Yoshio ^a   Hashimoto, Kazuaki ^a   Kawasaki, Masanori ^a   Takemura, Genzou ^a   Fujiwara, Takako ^b   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

Glycogen; Ischaemia; Myocardial infarction; Myocardium; glucosidase inhibitor

Indexed keywords

GLUCOSE; GLYCOGEN; LACTIC ACID; MIGLITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCOGEN ANALYSIS; GLYCOGENOLYSIS; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0033406658     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702970     Document Type: Article

References (35)

1. ARAI, M., MINATOGUCHI, S., TAKEMURA, G., UNO, Y., KARIYA, T., TAKATSU, H., FUJIWARA, T., HIGASHIOKA, M., YOSHIKUNI, Y. & FUJIWARA, H. (1998). N-methyl-1-deoxynojirimycin (MOR-14), an α-glucosidase inhibitor, markedly reduced infarct size in rabbit hearts. Circulation, 97, 1290-1297.
2. AUCHAMPACH, J.A. & GROSS, G.J. (1993). Anti-ischemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs. Eur. Heart J., 14, 10-15.
3. BARBOSA, V., SIEVERS, R.E., ZAUGG, C.E. & WOLFE, C. (1996). Preconditioning ischemia time determines the degree of glycogen depletion and infarct size reduction in rat hearts. Am. Heart J., 131, 224-230.
4. BERGMYER, H.U. (1974). Methods of Enzymatic Analysis. New York, NY: Academic Press Inc, vol 4, pp. 1446-1451.
5. BISCHOFF, H. (1994). Pharmacology of α-glucosidase inhibition. Eur. J. Clin. Invest., 24 (Suppl 3), 3-10.
6. BOLLEN, M. & STALMANS, W. (1989). The antiglycogenolytic action of 1-deoxynojirimycin results from a specific inhibition of the α-1,6-glucosidase activity of the debranching enzyme. Eur. J. Biochem., 181, 775-780.
7. BOLLEN, M., VANDEBROECK, A. & STALMANS, W. (1988). 1-Deoxynojirimycin and related compounds inhibit glycogenolysis in the liver without affecting the concentration of phosphorylase a. Biochem. Pharmacol., 37, 905-909.
8. FISHBEIN, M.C., MEERBAUM, S., RIT, J., LANDO, U., KANMATSUSE, K., MERCIER, J.C., CORDAY, E. & GANZ, W. (1981). Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am. Heart J., 101, 593-600.
9. FUJIWARA, H., ONODERA, T., TANAKA, M., MIYAZAKI, S., WU, D.J., MATSUDA, M., KAWAMURA, A., ISHIDA, M., GENZOU, T., FUJIWARA, Y., FUJIWARA, T. & KAWAI, C. (1989). Acceleration of cell necrosis following reperfusion after ischemia in the pig heart without collateral circulation. Am. J. Cardiol., 63, 14E-18E.
10. GOTO, M., LIU, Y., YANG, XI-M., ARDELL, J.L., COHEN, M.V. & DOWNEY, J.M. (1995). Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ. Res., 77, 611-621.
11. GROSS, G.J. & AUCHAMPACH, J.A. (1992). Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res., 70, 223-233.
12. HARKEN, A.H., SIMSON, M.B., HASELGROVE, J., WESTEIN, L., HARDEN, W.R. & BARLOW, C.H. (1981). Early ischemia after complete coronary ligation in the rabbit, dog, pig and monkey. Am. J. Physiol., 241, H202-H210.
13. HULIN, B. (1994). New hypoglycemic agents. Prog. Med. Chem., 31, 1-58
14. ITOYA, M., MIURA, T., SAKAMOTO, J., URABE, K. & IIMURA, O. (1994). Nucleoside transport inhibitors enhance the infarct size-reducing effect of ischemic preconditioning. J. Cardiovasc. Pharmacol., 24, 846-852.
15. JENNINGS, R.B., MURRY, C.E. & REIMER, K.A. (1991). Energy metabolism in preconditioned and control myocardium: effect of total ischemia. J. Mol. Cell Cardiol., 23, 1449-1458.
16. KARIYA, T., MINATOGUCHI, S., OHNO, T., YAMASHITA, K., UNO, Y., ARAI, M., KOSHIJI, M, FUJIWARA, T. & FUJIWARA, H. (1997). Infarct size-reducing effect of ischemic preconditioning is related to α1b-adrenoceptors but not to α1a-adrenoceptors in rabbits. J. Cardiovasc. Pharmacol., 30, 437-445.
17. KEPPLER, W. & DECKER, K. (1984). Methods of Enzymatic Analysis. New York, NY: Academic Press Inc, vol 6, pp. 11-18.
18. KERSTEN, J.R., SCHMELING, T.J., ORTH, K.G., PAGEL, P.S. & WARLTIER, D.C. (1998). Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am. J. Physiol., 275, H721-H725.
19. KIDA, M., FUJIWARA, H., ISHIDA, M., KAWAI, C., OHURA, M., MIURA, I. & YABUUCHI, Y. (1991). Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation, 84, 2495-2503.
20. LI, Y.W., WHITTAKER, P. & KLONER, R.A. (1992). The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am. Heart J., 123, 346-353.
21. LIU, G.S., THORNTON, J., VAN WINKLE, D.M., STANLEY, A.W., OLSSON, R.A. & DOWNEY, J.M. (1991). Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation, 84, 350-356.
22. MCNULTY, P.H., DARLING, A. & WHITING, J.M. (1996). Glycogen depletion contributes to ischemic preconditioning in the rat heart in vivo. Am. J. Physiol., 271, H2283-H2289.
23. MIURA, T., OGAWA, T., IWAMOTO, T., SHIMAMOTO, K. & IIMURA, O. (1992). Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation, 86, 979-985.
24. MURRY, C.E., JENNINGS. R.B. & REIMER, K.A. (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 74, 1124-1136.
25. MURRY, C.E., RICHARD, V.J., REIMER, K.A. & JENNINGS, R.B. (1990). Ischemic preconditioning slows energy metabolism and delays unstructured damage during a sustained ischemic episode. Circ. Res., 66, 913-931.
26. NAKAGAWA, Y., ITO, H., KITAKAZE, M., KUSUOKA, H., HORI, M., KUZUYA, T., HIGASHINO, Y., FUJII, K. & MINAMINO, T. (1995). Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of 'preconditioning'. J. Am. Coll. Cardiol., 25, 1076-1083.
27. NEELY, J.R. & GROTYOHANN, L.W. (1984). Role of glycolytic products in damage to ischemic myocardium: dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts. Circ. Res., 55, 816-824.
28. PAGANO, G., MARENA, S., CORGIAT-MANSIN, L., CRAVERO, F., GIORDA, C., BOZZA, M. & ROSSI, C.M. (1995). Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients. Diabete Metab., 21, 162-167.
29. SCHNACK, C., PRAGER, R.J.F., WINKLER, J., SCHNEIDER, B.G. & SCHERNTHANER, G. (1989). Effect of 8-wk α-glucosidase inhibition on metabolic control, c-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes Care, 12, 537-543.
30. SCHOTT, R.J., ROHMANN, S., BRAUN, E.R. & SCHAPER, W. (1990). Ischemic preconditioning reduces infarct size in swine myocardium. Circ. Res., 66, 1133-1142.
31. TANAKA, M., FUJIWARA, H., YAMASAKI, K. & SASAYAMA, S. (1994). Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischemic preconditioning in the rabbit. Cardiovasc. Res., 28, 980-986.
32. THORNTON, J., STRRIPLIN, S., LIU, G.S., SWAFFORD, A., STANLEY, A.W., VAN WINKEL, D.M. & DOWNEY, J.M. (1990). Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am. J. Physiol., 259, H1822-H1825.
33. WOLFE, C.L., GILBERT, H.F., BRINDLE, K.M. & RADDA, G.K. (1988). Determination of buffering capacity of rat myocardium during ischemia. Biochim. Biophys. Acta, 971, 9-20.
34. WOLFE, C.L., SIEVERS, R.E., VISSERREN, F.L. & DONNELLY, T.J. (1993). Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation, 87, 881-892.
35. YTREHUS, K., LIU, Y. & DOWNEY, J.M. (1994). Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Physiol., 266, H1145-H1152.